Skip to main navigation

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join
Our Team
- Who We Are
- Benefits
- Join Us
- Awards
Contact

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join
Our Team
- Who We Are
- Benefits
- Join Us
- Awards
Contact

Investors & Media

Investor Overview
Stock Information
- Stock Quote
- Stock Chart
Press Releases
Events and Presentations
Corporate Governance
Financial Information
- SEC Filings
Annual Reports
Analyst Coverage
Investor FAQs
Contact Us

Press Releases

Keyword Search

Year

Nov 9, 2020

Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates

Oct 12, 2020

Voyager Therapeutics Provides Regulatory Update on VY-HTT01 Program

Oct 1, 2020

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 15, 2020

Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors

Sep 14, 2020

Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources Officer

Sep 11, 2020

Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson’s Disease

Sep 3, 2020

Voyager Therapeutics Announces Upcoming Presentations at the International Parkinson and Movement Disorder Society Virtual Congress 2020

Aug 10, 2020

Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates

Aug 3, 2020

Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor Conferences

Aug 3, 2020

Voyager Therapeutics Provides Update on AbbVie Vectorized Antibody Collaborations

Jun 16, 2020

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 6, 2020

Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates

Apr 29, 2020

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2020 Annual Meeting

Apr 3, 2020

Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial

Mar 9, 2020

Voyager Therapeutics Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference

Mar 3, 2020

Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates

Feb 26, 2020

Voyager Therapeutics to Participate in Upcoming Investor Conferences

Feb 25, 2020

Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020

Print Page
RSS Feeds
Share Page
X
- Share on:
- Facebook
- Twitter
- LinkedIn
- Google+
- Reddit
- Digg
- Google
- Delicious
- StumbleUpon
E-mail Alerts
IR Contacts

Data provided by Nasdaq. Minimum 15 minutes delayed.

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join Our
Team
Contact

© Voyager Therapeutics All rights served.

LinkedIn
Terms of Use
Sitemap